Proton Radiation Therapy for Benign and Slow-Growing Brain Tumors

This trial is studying proton radiation therapy, a type of targeted radiation treatment that aims to destroy or shrink benign (non-cancerous) or slow-growing brain tumors in adults. Researchers want to measure how well the treatment controls the tumor, how it affects your quality of life, and what side effects you might experience—both in the short term and up to 5 years after treatment.

While proton radiation therapy has been approved by the FDA for other conditions, it hasn't been officially approved specifically for benign and slow-growing brain tumors. This trial will gather evidence to understand whether this targeted form of radiation is safe and effective for these particular tumors, and how it compares to what we currently know about quality of life outcomes.